Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Monthly Archives: March 2022

Studies Advance Lexaria Bioscience Corp.’s (NASDAQ: LEXX) Technology for Significantly Improving Pharmaceutical Drugs

Posted on March 4, 2022 by MissionIR

Lexaria Bioscience is dedicated to applying its patented technology to pharmaceutical drug offerings to enhance their performance and speed their rate of effective use The company’s flagship DehydraTECH(TM) technology has delivered numerous successes in studies of its potential for treating … Continue reading →

Posted in Lexaria Bioscience Corp. LEXX, Small Cap News | Leave a comment

SRAX Inc. (NASDAQ: SRAX) Foresee Surging Revenue as Millennials are All-In on Corporate Transparency

Posted on March 4, 2022 by MissionIR

SaaS company SRAX offers a robust suite of cutting-edge products that facilitate engagement between public companies and investors, both existing and potential SRAX forecasts a record first quarter of $11.5 million in revenue as part of 2022 revenue in the … Continue reading →

Posted in SRAX, Inc. SRAX | Leave a comment

MissionIRNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Expanding Portfolio, Presence in Growing Rare Cannabinoid Market

Posted on March 3, 2022 by MissionIR

InMed Pharmaceuticals (NASDAQ: INM) is uniquely positioned to leverage the growing worldwide awareness of the potential of cannabinoids and the rising demand for rare cannabinoids. The company has begun this year on a high, following the 2021 acquisition of BayMedica … Continue reading →

Posted in InMed Pharmaceuticals Inc. INM | Leave a comment

MissionIRNewsBreaks – Lexaria Bioscience Corp.’s (NASDAQ: LEXX) DehydraTECH(TM) Demonstrates Faster, Higher Overall Delivery of Sildenafil into Bloodstream

Posted on March 3, 2022 by MissionIR

Lexaria Bioscience Corp. (NASDAQ: LEXX) recently released positive results from an animal study that evaluated DehydraTECH(TM) processing of the phosphodiesterase inhibitor (“PDE5 inhibitor”) sildenafil as potential use in the management of erectile dysfunction. “A clear trend emerged during the course … Continue reading →

Posted in Lexaria Bioscience Corp. LEXX | Leave a comment

MissionIRNewsBreaks – GreenBox POS (NASDAQ: GBOX) Enters ACH Payment Processing Vertical, Opening Profitable Multimillion Revenue Stream

Posted on March 3, 2022 by MissionIR

GreenBox (NASDAQ: GBOX), an innovative blockchain ledger fintech company, recently announced it would offer Automated Clearing House (“ACH”) processing capabilities to merchants leveraging its blockchain technology and smart contract technology to transfer funds electronically for ACH debit and credit transactions. … Continue reading →

Posted in GreenBox POS. GBOX | Leave a comment

MissionIRNewsBreaks – Knightscope Inc.’s (NASDAQ: KSCP) K5 ASR to Boost Security Presence for New Texas-Based Client

Posted on March 3, 2022 by MissionIR

Knightscope (NASDAQ: KSCP), a developer of advanced physical security technologies focused on enhancing U.S. security operations, today announced that a Texas-based manufacturer of premium quality lubricants and associated products for the automotive, industrial and drilling markets will soon be welcoming … Continue reading →

Posted in Knightscope Inc. KSCP | Leave a comment

MissionIRNewsBreaks – PlantX Life Inc. (CSE: VEGA) (Frankfurt: WNT1) (OTCQB: PLTXF) Launches Same-Day Delivery in Chicago, Plainfield Areas

Posted on March 3, 2022 by MissionIR

PlantX Life (CSE: VEGA) (Frankfurt: WNT1) (OTCQB: PLTXF) has announced that it will be offering same-day delivery for its products across Chicago and Plainfield, IL. The company noted that this new offering is possible because of the company’s acquisition of Peter Rubi LLC, which … Continue reading →

Posted in PlantX Life Inc. PLTXF | Leave a comment

MissionIRNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Announces 2021 Financial Results, Corporate Update

Posted on March 3, 2022 by MissionIR

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system (“CNS”), today reported its financial results for the year ended Dec. 31, 2021. The … Continue reading →

Posted in CNS Pharmaceuticals Inc. CNSP | Leave a comment

MissionIRNewsBreaks – Pressure BioSciences Inc. (PBIO), Ohio State New Tech Featured in Newly Installed Food Processing Equipment

Posted on March 3, 2022 by MissionIR

Pressure BioSciences (OTCQB: PBIO), a Massachusetts-based company that manufactures high pressure-based equipment and laboratory instrumentation for the life sciences industry, has been working with The Ohio State University College of Food, Agricultural, and Environmental Sciences (“CFAES”) to develop new technology … Continue reading →

Posted in Pressure BioSciences Inc. PBIO | Leave a comment

Knightscope, Inc. (NASDAQ: KSCP) Ramps Up Investor Relations Efforts with Dedicated Investor Deck as It Continues its Journey Toward Making the U.S. the Safest Country Globally Through the Application of Advanced Robotics Technology

Posted on March 3, 2022 by MissionIR

Knightscope’s shares began trading publicly on the Nasdaq Global Market on January 27, following the closing of a public offering that kicked off in early December Following the public offering, Knightscope has entered its 2nd chapter as it continues to … Continue reading →

Posted in Knightscope Inc. KSCP | Leave a comment